]> 2026-07-31T14:08:22+00:00 WBR0567 0 en Metaplasia Barrett's esophagus is a form of glandular metaplasia whereby normal esophageal nonkeratinized stratified squamous epithelium is replaced by glandular columnar epithelium. Dysplasia Dysplasia is a reversible abnormal growth with loss of cellular shape, size, and orientation. Barrett's esophagus, ''per se'', is not a form of dysplasia. Nonetheless, long-standing Barrett's esophagus may result in low grade dysplasia, then high grade dysplasia, and finally esophageal adenocarcinoma. Desmoplasia Desmoplasia is the formation of fibrous or connective tissue usually secondary to a neoplasm. Barrett's esophagus is not a form of desmoplasia. Several cutaneous and visceral cancers may be associated with desmoplasia.. Neoplasia Neoplasia is the irreversible clonal proliferation of cells with uncontrolled growth. Barrett's esophagus is not a form of neoplasia. However, it can result in adenocarcinoma. Hyperplasia Hyperplasia is defined as tissue growth due to the increase in the number of cells. Barrett's esophagus is not a form of hyperplasia. An example of hyperplasia is benign prostate hyperplasia (BPH) among men older than 50 years of age. Barrett's esophagus is a form of glandular metaplasia, defined as loss of the normal non-keratinized stratified squamous epithelium of the distal esophagus. Instead, the epithelium is replaced by abnormal glandular columnar epithelium which resembles that of the duodenum. Barrett's esophagus is a premalignant lesion among the majority of patients with esophageal adenocarcinoma. The definitive diagnosis of Barrett's esophagus is based on endoscopic biopsy of the distal esophagus. Barrett's esophagus is a clinical concern due to its predisposition to adenocarcinoma of the esophagus. Barrett's esophagus is a common complication of long-standing gastroesophageal reflux disease (GERD). In addition to GERD and GERD symptoms, the most important risk factors for the development of Barrett's esophagus include obesity, advanced age, male sex, and white race. Patients with Barrett's esophagus are approximately 30-40 times more likely to develop esophageal adenocarcinoma compared to patients with no Barrett's esophagus, which justifies why close follow-up and multiple endoscopies to screen for dysplasia and adenocarcinoma are indicated once the diagnosis is made. Treatment of Barrett's esophagus and prevention of dysplasia are generally by aggressive management of GERD using acid-suppressive therapy.<br/> '''Educational Objective:''' Barrett's esophagus is a premalignant lesion of the distal esophagus. It is a form of metaplasia, whereby normal esophageal nonkeratinized stratified squamous epithelium is replaced by glandular columnar epithelium.<br/> '''References:''' Sharma P. Barrett's esophagus. N Engl J Med. 2009;361:2548-56.<br> Sjogren RW, Johnson LF. Barrett's esophagus: a review. Am J of Med. 1983; 74(2):313-321.<br> First Aid 2014 page 350 Pathology A Gastrointestinal 2020-10-28T00:59:07Z 2459150.5410532 WBR0567